CIK 0001782223 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pyxis Oncology, Inc.
Sign in to watch- Ticker
- PYXS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831160910
- Phone
- (617) 221-9059
- Business address
- 321 HARRISON AVENUE, BOSTON, MA, 02118
- Open-market buys, last 90 days
- $0
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-07 | Palani Santhosh Director | Grant or award | +6,000 | 6,000 | ||
| 2024-03-26 | Connealy Pamela Ann CFO & COO | Grant or award | +328,710 | 1,110,293 | ||
| 2024-03-26 | Sullivan Lara Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,071,242 | $3.83 | $4.1M | 1,071,242 |
| 2024-03-26 | Cline Darren S Director | Grant or award | +35,219 | 251,405 | ||
| 2024-03-26 | FLAVIN JOHN L Director | Grant or award | +35,219 | 413,015 | ||
| 2024-03-26 | Lewis-Hall Freda C Director | Grant or award | +35,219 | 241,405 | ||
| 2024-03-26 | Dupont Jakob Director | Grant or award | +38,741 | 38,741 | ||
| 2024-03-26 | HUMPHREY RACHEL Director | Grant or award | +38,741 | 96,805 | ||
| 2024-03-26 | Civik Thomas Director | Grant or award · Stock Option (Right to Buy) | +44,024 | $3.83 | $169K | 44,024 |
| 2024-03-26 | Wadhane Jitendra SVP, Chief Accounting Officer | Grant or award | +131,484 | 398,421 | ||
| 2024-03-12 | Palani Santhosh Director | Grant or award · Stock Option (Right to Buy) | +69,760 | 69,760 | ||
| 2023-12-29 | Kobayashi Ken Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +443,514 | 443,514 | ||
| 2023-12-29 | Kobayashi Ken Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +110,878 | 110,878 | ||
| 2023-11-29 | Connealy Pamela Ann CFO and COO | Shares withheld for taxes | −36,949 | $1.40 | $52K | 781,583 |
| 2023-11-15 | Wadhane Jitendra Chief Accounting Officer | Grant or award | +40,000 | 266,937 | ||
| 2023-09-28 | Connealy Pamela Ann CFO and COO | Purchase | +8,000 | $1.87 | $15K | 818,532 |
| 2023-09-27 | Wadhane Jitendra Chief Accounting Officer | Purchase | +2,500 | $1.87 | $5K | 226,937 |
| 2023-09-27 | Connealy Pamela Ann CFO and COO | Purchase | +6,426 | $1.85 | $12K | 810,532 |
| 2023-09-25 | Wadhane Jitendra Chief Accounting Officer | Purchase | +5,000 | $1.77 | $9K | 224,437 |
| 2023-09-25 | Connealy Pamela Ann CFO and COO | Purchase | +12,000 | $1.67 | $20K | 804,106 |
Page 3 of 7 · 137 trades